The benefits of sequencing adjuvant tamoxifen and anastrozole in postmenopausal women with hormone-responsive early breast cancer: 5 year-analysis of ABCSG Trial 8

被引：0
|
作者：
Jakesz, R [1 ]
Gnant, M [1 ]
Greil, R [1 ]
Tausch, C [1 ]
Samonigg, H [1 ]
Kwasny, W [1 ]
Kubista, E [1 ]
Stierer, M [1 ]
Luschin, G [1 ]
Mittlboeck, M [1 ]
机构：
[1] Vienna Med Sch, Vienna, Austria
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 50 条
  • [1] Switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-responsive early breast cancer: a meta-analysis of the ARNO 95 Trial, ABCSG Trial 8, and the ITA Trial.
    Jonat, W
    Gnant, M
    Boccardo, F
    Kaufmann, M
    Rubagotti, A
    Jakesz, R
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S11 - S11
  • [2] Tamoxifen and anastrozole as a sequencing strategy in postmenopausal women with hormone-responsive early breast cancer: updated data from the Austrian breast and colorectal cancer study group trial 8
    Jakesz, R.
    Gnant, M.
    Griel, R.
    Tausch, C.
    Samonigg, H.
    Kwasny, W.
    Kubista, E.
    Stierer, M.
    Luschin, G.
    Rueecklinger, E.
    Mittlboeck, M.
    CANCER RESEARCH, 2009, 69 (02) : 67S - 67S
  • [3] Should women with early hormone-responsive breast cancer be switched from tamoxifen to anastrozole?
    Alexander HG Paterson
    Nature Clinical Practice Oncology, 2006, 3 : 80 - 81
  • [4] Should women with early hormone-responsive breast cancer be switched from tamoxifen to anastrozole?
    Paterson, AHG
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (02): : 80 - 81
  • [5] Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial
    Jakesz, R
    Jonat, W
    Gnant, M
    Mittlboeck, M
    Greil, R
    Tausch, C
    Hilfrich, J
    Kwasny, W
    Menzel, C
    Samonigg, H
    Seifert, M
    Gademann, G
    Kaufmann, M
    LANCET, 2005, 366 (9484): : 455 - 462
  • [6] Benefits of switching postmenopausal women with hormone-sensitive early breast cancer to anastrozole after 2 years adjuvant tamoxifen: combined results from 3123 women enrolled in the ABCSG Trial 8 and the ARNO 95 Trial
    BREAST, 2005, 14 : S38 - S38
  • [7] Endocrine Effects of Adjuvant Letrozole Compared With Tamoxifen in Hormone-Responsive Postmenopausal Patients With Early Breast Cancer: The HOBOE Trial
    Rossi, Emanuela
    Morabito, Alessandro
    Di Rella, Francesca
    Esposito, Giuseppe
    Gravina, Adriano
    Labonia, Vincenzo
    Landi, Gabriella
    Nuzzo, Francesco
    Pacilio, Carmen
    De Maio, Ermelinda
    Di Maio, Massimo
    Piccirillo, Maria Carmela
    De Feo, Gianfranco
    D'Aiuto, Giuseppe
    Botti, Gerardo
    Chiodini, Paolo
    Gallo, Ciro
    Perrone, Francesco
    de Matteis, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) : 3192 - 3197
  • [8] Benefits of switching postmenopausal women with hormone-sensitive early breast cancer to anastrozole after 2 years adjuvant tamoxifen: combined results from 3,123 women enrolled in the ABCSG trial 8 and the ARNO 95 trial
    Jakesz, R
    Kaufmann, M
    Gnant, M
    Jonat, W
    Mittlboeck, M
    Greil, R
    Tausch, C
    Hilfrich, J
    Kwasny, W
    Samonigg, H
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S7 - S7
  • [9] Two years of tamoxifen followed by 3 years of anastrozole versus 5 years of tamoxifen alone in postmenopausal women with hormone-responsive early breast cancer: Efficacy results from 3,714 patients from the Austrian Breast and Colorectal Cancer Study Group (ABCSG) trial 8.
    Dubsky, P. C.
    Jakesz, R.
    Greil, R.
    Heck, D.
    Stoeger, H.
    Kwasny, W.
    Menzel, C.
    Singer, C. F.
    Medl, M.
    Gnant, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer
    Bago-Horvath, Zsuzsanna
    Rudas, Margaretha
    Dubsky, Peter
    Jakesz, Raimund
    Singer, Christian F.
    Kemmerling, Ralf
    Greil, Richard
    Jelen, Andrea
    Boehm, Gerhard
    Jasarevic, Zerina
    Haid, Anton
    Gruber, Christine
    Poestlberger, Sabine
    Filipits, Martin
    Gnant, Michael
    CLINICAL CANCER RESEARCH, 2011, 17 (24) : 7828 - 7834
12345